TY - CHAP M1 - Book, Section TI - Teachers' Guides to the Users' Guides A1 - Wyer, Peter A1 - Cook, Deborah J. A1 - Vandvik, Per Olav A1 - Richardson, W. Scott A1 - Elbarbary, Mahmoud A1 - Kunz, Regina A1 - Wilson, Mark C. A2 - Guyatt, Gordon A2 - Rennie, Drummond A2 - Meade, Maureen O. A2 - Cook, Deborah J. PY - 2015 T2 - Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed AB - CLINICAL SCENARIOScenario 1You are an attending physician in your hospital's intensive care unit (ICU) doing morning rounds on a patient with septic shock. The resident notes that the patient is still hypotensive after receiving 5 L of intravenous Ringer's lactate solution and asks if starch solution should be administered.Scenario 2You are awaiting the noon conference in the ICU where a patient admitted that week will be discussed in detail with 2 attending physicians, a fellow, 2 senior residents, and 2 junior residents. The fellow is now addressing preventive interventions as part of admission orders, noting that this patient did not receive heparin thromboprophylaxis when first admitted because his admitting diagnosis was ruptured abdominal aortic aneurysm. Now, 2 days after the patient's surgery, the fellow is wondering which type of heparin to prescribe.Scenario 3You are the faculty adviser for journal club in your surgical residency program. The resident assigned to lead this month's session attended the patient admitted from the emergency department with ruptured aortic aneurysm from scenario 2. She proposes to review the literature on the choice of low-molecular-weight heparin vs other prophylactic alternatives for postoperative patients. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/06 UR - jamaevidence.mhmedical.com/content.aspx?aid=1183878585 ER -